treatment

ASH 2021 Updates: MDS and Secondary AML

Thumbnail for video Watch Now

Topic(s)
Acute Myeloid Leukemia (AML)
Presenter(s)
Elizabeth Griffiths, MD
In this webinar, Dr. Elizabeth Griffiths discusses research most relevant to patients reported over the past year on the biology and treatment on MDS and secondary AML. These studies were presented at the American Society of Hematology (ASH) 2021 meeting in Atlanta, GA. Research…

Structural Racism is a Mediator of Disparities in Acute Myeloid Leukemia Outcomes

Original Publication Date
Article Source
External Web Content
Key Points Structural racism (SR) assessed by census tract variables accounts for nearly all Black-white and Hispanic-white disparity in AML survival. Structural Racism is a stronger mediator of survival disparities than molecular features, co-morbidities, healthcare access and…

What's My Doctor Thinking? Treating Secondary AML

Thumbnail for video Watch Now

Topic(s)
Acute Myeloid Leukemia (AML)
Presenter(s)
Firas El Chaer, MD
In this webinar, Dr. Firas El Chaer discusses the diagnosis of secondary AML and how treatment options are decided . Secondary acute myeloid leukemia (AML) refers to a condition in patients who have had prior myelodysplasia (MDS), myeloproliferative disorder, or aplastic anemia…

Firas El Chaer, MD

Institution
University of Virginia
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
About
Firas El Chaer, MD, is an assistant professor of medicine who specializes in hematology and oncology. His clinical areas of interest are acute leukemia, chronic leukemia, myelodysplastic syndrome, myeloproliferative disorders, aplastic anemia, clonal hematopoiesis and blood disorders. His research focuses on improving outcomes for acute leukemia in adults by focusing on targeted therapies and overcoming resistance mechanisms. Dr. El Chaer attended medical school at the University of Balamand in Beirut, Lebanon, and completed his internal medicine residency at the Icahn School of Medicine at

Student view: Donor diversity saves lives

Original Publication Date
Article Source
External Web Content
Editor's note: Here's an update on Mychaela (see Stories of Hope) Mychaela Lovelace is a sophomore at Michigan State University majoring in kinesiology in the College of Education, and is a scholar and mentor in the Dow STEM Scholars Program. On April 1, 2008, at the age of 5 I…

Zohra Nooruddin, MD

Institution
Mays Cancer Center at UT Health San Antonio MD Anderson
Physician Status
accepting new patients
About
Zohra Nooruddin, MD received her medical degree from Ziauddin Medical University in Karachi, Pakistan, and attended Mount Sinai School of Medicine in Englewood, New Jersey for her residency. Dr. Nooruddin completed a fellowship in symptom control and palliative care at The University of Texas MD Anderson Cancer Center in Houston, and a fellowship in hematology-oncology at the University of Colorado Denver. She is board-certified in hospice and palliative medicine, and in hematology and oncology.
Subscribe to treatment

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.